期刊文献+

沙眼衣原体疫苗研究的新进展 被引量:1

Update on the vaccine of Chlamydia trachomatis
原文传递
导出
摘要 沙眼衣原体感染是当今世界上最常见的性传播疾病,而疫苗一直是令人期待的预防和治疗沙眼衣原体感染的有效方法。20多年来临床医生及研究者做出了不懈的努力,近年来的研究主要集中于蛋白或多肽疫苗、树突状细胞疫苗和核酸疫苗上,其中尤以核酸疫苗引人注目。主要针对这三种疫苗,综述选用不同的载体、免疫佐剂及免疫途径等方法取得的成果及存在的缺陷,并探讨实施最佳免疫路径和发展新型疫苗的可能性等问题。 The infection of Chlamydia trachomatis is the most commonly sexually transmitted disease in the world, and vaccine has been expected to be an effective way to prevent and treat the infection. Many efforts have been offered to this field by clinicians and scientific researchers in the past twenty years. Recently, the studies are mainly concentrated on polypeptide vaccine, dendritic cell vaccine and DNA vaccine, and especially on DNA vaccine. This paper presents the progresses and problems in the researches about the vectors, immune adjuvants and immunization routes of the three kinds of vaccines. Also, the best immunization approach and possibility of new vaccine development are discussed.
作者 王艳 刘全忠
出处 《国际皮肤性病学杂志》 2008年第1期20-22,共3页 International Journal of Dermatology and Venereology
关键词 衣原体 沙眼 疫苗 Chlamydia trachomatis Vaccines
  • 相关文献

参考文献16

  • 1Debattista J, Timms P, Allan J, et al. Immunopathogenesis of Chlamydia trachomatis infections in women. Fertil Steril, 2003, 79(6): 1273-1287.
  • 2Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect Immun, 2002, 70(6): 2741-2751.
  • 3Pal S, Peterson EM, de la Maza LM. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun, 2005, 73 (12): 8153-8160.
  • 4Singh SR, Hulett K, Pillai SR, et al. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection. Vaccine, 2006, 24( 8 ): 1213-1224.
  • 5Murthy AK, Chambers JP, Meier PA, et al. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun, 2007, 75(2): 666-676.
  • 6Crane DD, Carlson JH, Fischer ER, et al. Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen. Proc Natl Acad Sci U S A, 2006, 103 (6): 1894-1899.
  • 7Yang X. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr Pharm Des, 2003, 9( 1 ): 67-73.
  • 8Rey-Ladino J, Koochesfahani KM, Zaharik ML, et al. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct. Infect Immun, 2005, 73 (3): 1568-1577.
  • 9Shaw J, Grund V, Durling L, et al, Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4^+ type 2 rather than type 1 immune response that is not protective. Infect Immun, 2002, 70(3): 1097-1105.
  • 10Cid-Arregui A, Juarez V, zur Hausen H. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J Virol, 2003, 77( 8 ): 4928-4937.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部